China Health EV / EBITDA
Mi az China Health EV / EBITDA?
A EV / EBITDA az China Health Group Inc. - 7.21
Mi a EV / EBITDA meghatározása?
Az EV / EBITDA a vállalati érték a kamat, az adózás, az értékcsökkenés és az amortizáció előtti eredményekkel elosztva. Ez azt jelenti, hogy mennyire drága egy állomány, és gyakrabban érvényesül a vállalatok közötti összehasonlításnál, mint az ár / nyereség arány. Megméri az árat (vállalati érték formájában), amelyet a befektető fizet a vállalat pénzforgalmának javára (EBITDA formájában).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA a Health Care szektor a HKSE-on cégekben a China Health -hoz képest
Mit csinál China Health?
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
ev / ebitda -hoz hasonló cégek China Health
- Bowl America nak EV / EBITDA 7.20 van
- Zhejiang Chang'an Renheng Technology Co nak EV / EBITDA 7.20 van
- Intense Technologies nak EV / EBITDA 7.20 van
- Zenitel NV nak EV / EBITDA 7.20 van
- Next Solar Fund nak EV / EBITDA 7.20 van
- DS Smith Plc nak EV / EBITDA 7.21 van
- China Health nak EV / EBITDA 7.21 van
- Bodal Chemicals nak EV / EBITDA 7.21 van
- V2X Inc nak EV / EBITDA 7.21 van
- Hertz Global nak EV / EBITDA 7.21 van
- Information Services nak EV / EBITDA 7.21 van
- Pathward Inc nak EV / EBITDA 7.21 van
- Impellam PLC nak EV / EBITDA 7.22 van